Incidence rates of post-ERCP complications: a systematic survey of prospective studies A Andriulli, S Loperfido, G Napolitano, G Niro, MR Valvano, F Spirito, ... Official journal of the American College of Gastroenterology| ACG 102 (8 …, 2007 | 1479 | 2007 |
Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia GE Boeckxstaens, V Annese, SB Varannes, S Chaussade, M Costantini, ... New England Journal of Medicine 364 (19), 1807-1816, 2011 | 997 | 2011 |
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3 A Mangia, R Santoro, N Minerva, GL Ricci, V Carretta, M Persico, F Vinelli, ... New England Journal of Medicine 352 (25), 2609-2617, 2005 | 849 | 2005 |
Genome-wide association identifies multiple ulcerative colitis susceptibility loci DPB McGovern, A Gardet, L Törkvist, P Goyette, J Essers, KD Taylor, ... Nature genetics 42 (4), 332-337, 2010 | 793 | 2010 |
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) guideline–updated June 2014 JM Dumonceau, A Andriulli, BJ Elmunzer, A Mariani, T Meister, J Deviere, ... Endoscopy 46 (09), 799-815, 2014 | 749 | 2014 |
European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis JM Dumonceau, A Andriulli, J Devière, A Mariani, J Rigaux, TH Baron, ... Endoscopy 42 (06), 503-515, 2010 | 493 | 2010 |
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis X Liu, P Invernizzi, Y Lu, R Kosoy, Y Lu, I Bianchi, M Podda, C Xu, G Xie, ... Nature genetics 42 (8), 658-660, 2010 | 472 | 2010 |
Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia NH Afdhal, EG Giannini, G Tayyab, A Mohsin, JW Lee, A Andriulli, ... New England Journal of Medicine 367 (8), 716-724, 2012 | 356 | 2012 |
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia V Annese, G Bassotti, G Coccia, M Dinelli, V D'Onofrio, G Gatto, ... Gut 46 (5), 597-600, 2000 | 344 | 2000 |
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial A Mangia, N Minerva, D Bacca, R Cozzolongo, GL Ricci, V Carretta, ... Hepatology 47 (1), 43-50, 2008 | 340 | 2008 |
Radiofrequency thermal ablation vs. percutaneous ethanol injection for small hepatocellular carcinoma in cirrhosis: meta-analysis of randomized controlled trials A Orlando, G Leandro, M Olivo, A Andriulli, M Cottone Official journal of the American College of Gastroenterology| ACG 104 (2 …, 2009 | 339 | 2009 |
Randomized controlled trial of botulinum toxin versus laparoscopic Heller myotomy for esophageal achalasia G Zaninotto, V Annese, M Costantini, A Del Genio, M Costantino, ... Annals of surgery 239 (3), 364-370, 2004 | 335 | 2004 |
Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis A Andriulli, G Leandro, G Niro, A Mangia, V Festa, G Gambassi, ... Gastrointestinal endoscopy 51 (1), 1-7, 2000 | 320 | 2000 |
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways HJ Cordell, Y Han, GF Mells, Y Li, GM Hirschfield, CS Greene, G Xie, ... Nature communications 6 (1), 8019, 2015 | 317 | 2015 |
Italian consensus guidelines for chronic pancreatitis L Frulloni, M Falconi, A Gabbrielli, E Gaia, R Graziani, R Pezzilli, G Uomo, ... Digestive and Liver Disease 42, S381-S406, 2010 | 297 | 2010 |
Pegylated interferon alpha‐2b as monotherapy or in combination with ribavirin in chronic hepatitis delta GA Niro, A Ciancio, GB Gaeta, A Smedile, A Marrone, A Olivero, ... Hepatology 44 (3), 713-720, 2006 | 294 | 2006 |
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial A Andriulli, R Clemente, L Solmi, V Terruzzi, R Suriani, A Sigillito, ... Gastrointestinal endoscopy 56 (4), 488-495, 2002 | 294 | 2002 |
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical … L Aabakken, TH Karlsen, J Albert, M Arvanitakis, O Chazouilleres, ... Endoscopy 49 (06), 588-608, 2017 | 286 | 2017 |
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies C Panebianco, A Andriulli, V Pazienza Microbiome 6, 1-13, 2018 | 281 | 2018 |
Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study A Iacobellis, M Siciliano, F Perri, BE Annicchiarico, G Leandro, N Caruso, ... Journal of hepatology 46 (2), 206-212, 2007 | 271 | 2007 |